...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis
【24h】

Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis

机译:PDAPP小鼠斑块形成之前的齿状回体积减小:磁共振显微镜和体视学分析

获取原文
获取原文并翻译 | 示例

摘要

High-resolution magnetic resonance microscopy (MRM) was used to determine regional brain volumetric changes in a mouse model of Alzheimer's disease. These transgenic (Tg) mice overexpress human mutant amyloid precursor protein (APP) V717F under control of platelet-derived growth factor promoter (PDAPP mice), and cortical and hippocampal beta-amyloid (Abeta) deposits accumulate in heterozygotes after 8-10 mos. We used MRM to obtain 3D volumetric data on mouse brains imaged in their skulls to define genotype- and age-related changes. Hippocampal, cerebellar, and brain volumes and corpus callosum length were quantified in 40-, 100-, 365-, and 630-day-old mice. Measurements taken at age 100 days, before Abeta deposition, revealed a 12.3% reduction of hippocampus volume in Tg mice compared with WT controls. This reduction persisted without progression to age 21 mos. A significant 18% increase in hippocampal volume occurred between 40 and 630days in WT mice, and no corresponding significant increase occurred in Tg mice. Cavalieri volume estimates of hippocampal subfields from 100-day-old Tg mice further localized a 28% volume deficit in the dentate gyrus. In addition, corpus callosum length was reduced by approximate to25% in Tg mice at all ages analyzed. In summary, reduced hippocampal volume and corpus callosum length can be detected by MIRM before Abeta deposition. We conclude that overexpression of APP and amyloid may initiate pathologic changes before the appearance of plaques, suggesting novel targets for the treatment of Alzheimer's disease and further reinforcing the need for early diagnosis and treatment. [References: 66]
机译:高分辨率磁共振显微镜(MRM)用于确定阿尔茨海默氏病小鼠模型中的局部脑体积变化。这些转基因(Tg)小鼠在血小板衍生的生长因子启动子(PDAPP小鼠)的控制下过表达人类突变体淀粉样前体蛋白(APP)V717F,并且8-10 mos后皮质和海马β-淀粉样蛋白(Abeta)沉积物积累在杂合子中。我们使用MRM来获取头骨上成像的小鼠大脑的3D体积数据,以定义与基因型和年龄相关的变化。在40、100、365和630日龄的小鼠中对海马,小脑和脑的体积以及and体长度进行了定量。在Abeta沉积之前在100天大的年龄进行的测量显示,与WT对照相比,Tg小鼠的海马体积减少了12.3%。这种减少持续到没有发展到21个月大。 WT小鼠在40到630天之间海马体积显着增加了18%,而Tg小鼠没有发生相应的显着增加。 100天大的Tg小鼠海马区的Cavalieri体积估计值进一步确定了齿状回中28%的体积缺陷。另外,在所有分析的年龄的Tg小鼠中,length体长度都减少了约25%。总而言之,MIRM可以在Abeta沉积之前检测到海马体积和体长度的减少。我们得出的结论是,APP和淀粉样蛋白的过度表达可能会在斑块出现之前引发病理变化,这提示了治疗阿尔茨海默氏病的新靶点,并进一步增强了早期诊断和治疗的需要。 [参考:66]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号